Af­ter sev­en months of search­ing, Lan­dos hires a CEO; Mar­ty Du­vall re-emerges from ill-fat­ed On­copep­tides tenure

Lan­dos Bio­phar­ma has land­ed a new CEO af­ter sev­en months of be­ing led by an in­ter­im chief ex­ec­u­tive.

Gre­go­ry Oakes took the helm of the au­toim­mune biotech this month, bring­ing with him near­ly 30 years of in­dus­try chops, most re­cent­ly as pres­i­dent of Vi­for Phar­ma’s North Amer­i­ca di­vi­sion and, be­fore that, VP at Cel­gene. Oakes al­so spent a bet­ter part of the 2010s at No­var­tis, mak­ing his way up to head of bio­phar­ma­ceu­ti­cals for gener­ics di­vi­sion San­doz.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Recon Strategy

Boston, MA, USA